Task: Answer the multiple choice question.
Question: Which drug exhibits a -4.076\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a Cc1cc(NC(=O)CCC(=O)N(CC(=O)NCC2CCCO2)c2ccc3c(c2)OCCO3)no1
b CCCCc1nnc(NC(=O)c2ccc3[nH]c(=O)c(=O)[nH]c3c2)s1
Answer: b. CCCCc1nnc(NC(=O)c2ccc3[nH]c(=O)c(=O)[nH]c3c2)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCc1nnc(NC(=O)c2ccc3[nH]c(=O)c(=O)[nH]c3c2)s1
CCCCc1nnc(NC(=O)c2ccc3[nH]c(=O)c(=O)[nH]c3c2)s1
N-(5-butyl-1,3,4-thiadiazol-2-yl)-2,3-dioxo-1,4-dihydroquinoxaline-6-carboxamide